Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Gait & Posture
|
March 18, 2014
Placement makes a difference: accuracy of an accelerometer in measuring step number and stair climbing
Cornelia Lützner, Heike Voigt, Ingo Roeder, et al.
European Journal of Dermatology : EJD
|
July 4, 2002
Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation
Jacques Louis, Alain Gumy, Heike Voigt, et al.
Journal of Cell Science
|
July 1, 2004
Overexpression of myosin IB in living Entamoeba histolytica enhances cytoplasm viscosity and reduces phagocytosis
Sabrina Marion, Claire Wilhelm, Heike Voigt, et al.
Molecular Cancer Therapeutics
|
February 5, 2009
MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
Roland Houben, Heike Voigt, Christiane Noelke, et al.
Experimental Dermatology
|
October 24, 2009
Mouse models for melanoma: a personal perspective
Jürgen C Becker, Roland Houben, David Schrama, et al.
Cancer Immunology, Immunotherapy : CII
|
September 15, 2005
Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells
David Schrama, Heike Voigt, Andreas O Eggert, et al.
Cancer Investigation
|
January 23, 2009
CD147 impacts angiogenesis and metastasis formation
Heike Voigt, Claudia S Vetter-Kauczok, David Schrama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 22, 2007
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma
Heike Voigt, Roland Houben, David Schrama, et al.
European Journal of Immunology
|
April 2, 2009
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
Uta B Hofmann, Heike Voigt, Mads H Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response
Selma Ugurel, Roland Houben, David Schrama, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Gait & Posture
|
March 18, 2014
Placement makes a difference: accuracy of an accelerometer in measuring step number and stair climbing
Cornelia Lützner, Heike Voigt, Ingo Roeder, et al.
European Journal of Dermatology : EJD
|
July 4, 2002
Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation
Jacques Louis, Alain Gumy, Heike Voigt, et al.
Journal of Cell Science
|
July 1, 2004
Overexpression of myosin IB in living Entamoeba histolytica enhances cytoplasm viscosity and reduces phagocytosis
Sabrina Marion, Claire Wilhelm, Heike Voigt, et al.
Molecular Cancer Therapeutics
|
February 5, 2009
MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
Roland Houben, Heike Voigt, Christiane Noelke, et al.
Experimental Dermatology
|
October 24, 2009
Mouse models for melanoma: a personal perspective
Jürgen C Becker, Roland Houben, David Schrama, et al.
Cancer Immunology, Immunotherapy : CII
|
September 15, 2005
Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells
David Schrama, Heike Voigt, Andreas O Eggert, et al.
Cancer Investigation
|
January 23, 2009
CD147 impacts angiogenesis and metastasis formation
Heike Voigt, Claudia S Vetter-Kauczok, David Schrama, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 22, 2007
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma
Heike Voigt, Roland Houben, David Schrama, et al.
European Journal of Immunology
|
April 2, 2009
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
Uta B Hofmann, Heike Voigt, Mads H Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response
Selma Ugurel, Roland Houben, David Schrama, et al.
Page
of 2